Senior insider sale
HALOZYME THERAPEUTICS, INC. — senior position signals high conviction
$310.3K
4.88K shares
What this filing means
CONNAUGHTON BERNADETTE plans to sell 4.88K shares of HALOZYME THERAPEUTICS, INC. valued at approximately $310.3K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/1/2026ACC: 0001950047-26-003926
Director
Since Sep 2018
4.88K
Shares to sell
$310.3K
Approx. market value
4.88K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Units
N/A
4/25/2025
4.88KTotal acquired4.88K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
4/25/2025 | Restricted Stock Units N/A | 4.88K | — |
| Total | 4.88K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
4.88K
Market value
$310.3K
5/1/2026
Total
Units
4.88K
Value
$310.3K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
5/1/2026 | 4.88K | $310.3K | NASDAQ | Planned |
| Total | 4.88K | $310.3K | ||